Research News and Research

RSS

Allos Therapeutics to raise funds for preclinical research and clinical development of FOLOTYN

Allos Therapeutics, Inc. today announced that it is offering to sell, subject to market and other conditions, 11,000,000 primary shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.

6 Oct 2009

Senate Democratic leaders prepare for floor action on health bills; public plan still the flashpoint

Democrats are preparing for floor action, with much of the attention centered on the Senate Finance Committee's final vote and merging two Senate reform bills.

6 Oct 2009

Scientists identify new interference method to target cancer cells

Professor Jo Milner and Dr Shafiq Ahmed, from the YCR P53 Research Unit in the Department of Biology, used a process called RNA interference to target the JNK2 gene in both cancer and healthy cells. The cancer cells died but the healthy cells were unaffected.

6 Oct 2009

Sequella receives ARRA funds to manufacture SQ109 for treating tuberculosis

Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $694,000 grant supplement as part of the American Recovery and Reinvestment Act (ARRA) of 2009.

6 Oct 2009

Sit-and-reach test to gauge age-related arterial stiffness

How far you can reach beyond your toes from a sitting position - normally used to define the flexibility of a person's body - may be an indicator of how stiff your arteries are.

6 Oct 2009

IBM scientists to build nanoscale DNA sequencer to read human DNA

In an effort to build a nanoscale DNA sequencer, IBM scientists are drilling nano-sized holes in computer-like chips and passing DNA strands through them in order to read the information contained within their genetic code.

6 Oct 2009

Otsuka Pharmaceutical provided access to BioWa's POTELLIGENT Technology platform

BioWa, Inc. announced today that it has entered into an agreement with Otsuka Pharmaceutical Co. Ltd. (Otsuka) to provide Otsuka with access to BioWa's POTELLIGENT® Technology platform for the research, development and commercialization of their antibody therapeutics with enhanced antibody-dependent cellular cytotoxicity (ADCC).

6 Oct 2009

HIV prevalence among African Americans is ten times greater than the prevalence among whites

HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.

6 Oct 2009

Molecular biologist receives 2009 Nobel Prize in Physiology or Medicine

Molecular biologist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco, today was named to receive the 2009 Nobel Prize in Physiology or Medicine.

6 Oct 2009

New York health workers protest H1N1 vaccine mandate

The first doses of H1N1 vaccines are expected to be released this week and a controversy brews as health workers protest a flu vaccine mandate. CBS News reports that health care workers in New York's capital "vowed to fight an unprecedented order from state health officials: a requirement for every health care worker to get seasonal and H1N1 flu shots or face the possibility of being fired."

6 Oct 2009

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.

6 Oct 2009

Group Health Research Institute to receive federal stimulus funds from ARRA

Group Health Research Institute, formerly Group Health Center for Health Studies, will receive more than $15 million in federal stimulus funding from ARRA, the American Recovery and Reinvestment Act of 2009.

6 Oct 2009

NIH awards Galenea a Challenge Grant for developing predictive in vivo models of cognition

Galenea Corp., a fully-integrated CNS drug discovery company, announced today that it has been awarded an NIH Challenge Grant in Health and Science Research (RC1) as part of the American Recovery and Reinvestment Act of 2009 (Recovery Act). This two-year grant from the National Institute of Mental Health addresses the specific topic of "Screening Approaches to Identify Pharmacologic Treatments for Mental Disorders" within the challenge area of Translational Science.

6 Oct 2009

Forsyth receives research grants from National Institutes of Health stimulus funding

Four Forsyth scientists have received grants from the latest round of National Institutes of Health stimulus funding through the American Recovery and Reinvestment Act (ARRA) of 2009. To date, Forsyth has received 13 ARRA grants totally nearly $6.4 million. The recent round of funding includes three highly competitive 'Challenge Grants'. The NIH received 22,000 submissions in the Challenge Grant competition ― only about 500 were funded.

6 Oct 2009

More than 1 million babies worldwide born prematurely die in first month, Study says

Each year more than 1 million babies born prematurely - before 37 weeks of development in the womb or within the first month of life - the "March of Dimes said Sunday in the first comprehensive global report on premature births," CNN reports. Nearly 10 percent of total births worldwide, or 12.9 million infants, are preterm, the study found.

6 Oct 2009

House leaders 'tantalizingly close' to finalizing bill - but work still remains

As House leaders prepare to advance their version of health reforms to the the floor, negotiations continue behind the scenes.

6 Oct 2009

Adverse childhood experiences double the risk of premature death

Many U.S. children face a terrible burden of stressors that can harm the development of their brains and nervous systems. These stressors can lead to health problems and diseases throughout their lives, ultimately causing some to die prematurely, according to the lead author of a new study.

6 Oct 2009

Depression leads to elevated inflammatory proteins in the human body: Study

To help solve this long standing chicken and egg conundrum, researchers led by Jesse Stewart, Ph.D., assistant professor of psychology at Indiana University-Purdue University Indianapolis asked two critical questions. Does depression lead to elevated inflammatory proteins in the human body? Or does an increase in these proteins lead to depression? They found that the answer to the first question appears to be "yes," and the answer to the second question may be "no" among healthy adults.

6 Oct 2009

Market for products positioned and marketed on the basis of ethical standards is thriving despite recession

The market for products positioned and marketed on the basis of ethical standards (eco-friendly/green, natural/organic, humane, and fair trade) is thriving despite the recession, reveals a new report by leading market research publisher Packaged Facts.

6 Oct 2009

Drivers with Parkinson's disease at greater risk of crashes on foggy days

Drivers with mild to moderate Parkinson's disease may be at higher risk of crashes on foggy days and other times of low visibility. The research, involving a driving simulation test, is published in the October 6, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.

6 Oct 2009

Research News and Research

Allos Therapeutics to raise funds for preclinical research and clinical development of FOLOTYN

Senate Democratic leaders prepare for floor action on health bills; public plan still the flashpoint

Scientists identify new interference method to target cancer cells

Sequella receives ARRA funds to manufacture SQ109 for treating tuberculosis

Sit-and-reach test to gauge age-related arterial stiffness

IBM scientists to build nanoscale DNA sequencer to read human DNA

Otsuka Pharmaceutical provided access to BioWa's POTELLIGENT Technology platform

HIV prevalence among African Americans is ten times greater than the prevalence among whites

Molecular biologist receives 2009 Nobel Prize in Physiology or Medicine

New York health workers protest H1N1 vaccine mandate

Schering-Plough receives FDA recommendation approval for PEGINTRON

Group Health Research Institute to receive federal stimulus funds from ARRA

NIH awards Galenea a Challenge Grant for developing predictive in vivo models of cognition

Forsyth receives research grants from National Institutes of Health stimulus funding

More than 1 million babies worldwide born prematurely die in first month, Study says

House leaders 'tantalizingly close' to finalizing bill - but work still remains

Adverse childhood experiences double the risk of premature death

Depression leads to elevated inflammatory proteins in the human body: Study

Market for products positioned and marketed on the basis of ethical standards is thriving despite recession

Drivers with Parkinson's disease at greater risk of crashes on foggy days

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics